| | | | | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | €1,2710 | +0,34% | €141,63M | €560,51K | |
NAZ Nuveen Arizona Quality Municipal Income Fund | €11,3227 | +1,55% | €141,61M | €28,62K | |
| €2,0939 | -2,80% | €141,55M | €295,33K | |
AMWL American Well Corporation | €7,2900 | -0,47% | €141,52M | €133,13K | |
| €45,2910 | -1,59% | €141,46M | €7,76K | |
SPRO Spero Therapeutics, Inc. Common Stock | €2,4128 | -1,06% | €141,19M | €649,12K | |
| €1,4649 | -3,95% | €141,00M | €695,22K | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | €8,8195 | -0,05% | €140,64M | €1,27K | |
GLQ Clough Global Equity Fund | €7,4451 | -0,35% | €140,63M | €54,81K | |
MNSB MainStreet Bancshares, Inc. Common Stock | €19,5864 | -2,15% | €140,37M | €31,42K | |
ORMP Oramed Pharmaceuticals Inc. | €3,1452 | +1,39% | €140,00M | €310,13K | |
CPSH CPS Technologies Corp. Common Stock | €6,7816 | -14,80% | €139,95M | €2,21M | |
NNY Nuveen New York Municipal Value Fund | €7,4105 | -0,23% | €139,79M | €17,67K | |
VTN Invesco Trust for Investment Grade New York Municipals | €9,5046 | +0,36% | €139,68M | €8,39K | |
KORE KORE Group Holdings, Inc. | €7,9190 | +0,00% | €139,12M | €20,57K | |
